rhamnose has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clementi, E; Corti, M; Guari, Y; Larionova, J; Lascialfari, A; Nano, R; Orlando, T; Paolini, A; Pasi, F; Pineider, F; Sacchi, L | 1 |
| de Lapuente, J; Guarch, CP; Guari, Y; Larionova, J; Lascialfari, A; Long, J; Nano, R; Paolini, A; Ramos-López, D | 1 |
2 other study(ies) available for rhamnose and Astrocytoma, Grade IV
| Article | Year |
|---|---|
NMR as evaluation strategy for cellular uptake of nanoparticles.
Topics: Antineoplastic Agents, Alkylating; Cell Line, Tumor; Dacarbazine; Ferric Compounds; Glioblastoma; Gold; Humans; Magnetic Resonance Spectroscopy; Nanoparticles; Rhamnose; Temozolomide | 2014 |
Rhamnose-coated superparamagnetic iron-oxide nanoparticles: an evaluation of their in vitro cytotoxicity, genotoxicity and carcinogenicity.
Topics: Animals; Carcinogens; Cell Line, Tumor; Cell Survival; Coated Materials, Biocompatible; Dextrans; DNA Damage; Glioblastoma; Humans; Hyperthermia, Induced; Magnetite Nanoparticles; Mice; Mice, Inbred BALB C; Reactive Oxygen Species; Rhamnose | 2016 |